Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Mona H. Haron, Bharathi Avula, Zulfiqar Ali, Amar G. Chittiboyina, Ikhlas A. Khan, Jing Li, Vivian Wang, Charles Wu & Shabana I. Khan. (2023) Assessment of Herb-Drug Interaction Potential of Five Common Species of Licorice and Their Phytochemical Constituents. Journal of Dietary Supplements 20:4, pages 582-601.
Read now
Read now
Megha Rachmale, Niraj Rajput, Tarang Jadav, Amit Kumar Sahu, Rakesh K. Tekade & Pinaki Sengupta. (2022) Implication of metabolomics and transporter modulation based strategies to minimize multidrug resistance and enhance site-specific bioavailability: a needful consideration toward modern anticancer drug discovery. Drug Metabolism Reviews 54:2, pages 101-119.
Read now
Read now
Jamie E. Moscovitz, Zhiwu Lin, Nathaniel Johnson, Meihua Tu, Theunis C. Goosen, Yan Weng & Amit S. Kalgutkar. (2018) Induction of human cytochrome P450 3A4 by the irreversible myeloperoxidase inactivator PF-06282999 is mediated by the pregnane X receptor. Xenobiotica 48:7, pages 647-655.
Read now
Read now
Michael W. Sinz. (2013) Evaluation of pregnane X receptor (PXR)-mediated CYP3A4 drug-drug interactions in drug development. Drug Metabolism Reviews 45:1, pages 3-14.
Read now
Read now
Ya-He Liu, Sui-Lin Mo, Hui-Chang Bi, Bing-Fang Hu, Chun Guang Li, Yi-Tao Wang, Ling Huang, Min Huang, Wei Duan, Jun-Ping Liu, Ming Qian Wei & Shu-Feng Zhou. (2011) Regulation of human pregnane X receptor and its target gene cytochrome P450 3A4 by Chinese herbal compounds and a molecular docking study. Xenobiotica 41:4, pages 259-280.
Read now
Read now
Articles from other publishers (70)
Shuang Xiang & Xiaoyun Lu. (2023) Selective Type II TRK inhibitors overcome xDFG mutation mediated acquired resistance to the second-generation inhibitors selitrectinib and repotrectinib. Acta Pharmaceutica Sinica B.
Crossref
Crossref
Weixing Zhang, Lei Guo, Haixia Liu, Guolong Wu, Houguang Shi, Mingwei Zhou, Zhisen Zhang, Buyu Kou, Taishan Hu, Zheng Zhou, Zhiheng Xu, Xue Zhou, Yuan Zhou, Xiaojun Tian, Guang Yang, John A. T. Young, Hongxia Qiu, Giorgio Ottaviani, Jianxun Xie, Alexander V. Mayweg, Hong C. Shen & Wei Zhu. (2023) Discovery of Linvencorvir (RG7907), a Hepatitis B Virus Core Protein Allosteric Modulator, for the Treatment of Chronic HBV Infection. Journal of Medicinal Chemistry 66:6, pages 4253-4270.
Crossref
Crossref
Qi Chen, Xin Zhou, Jessica Rehmel, James P. Steele, Kjell A. Svensson, James P. Beck, Erik J. Hembre & Junliang Hao. (2022) Ensemble Docking Approach to Mitigate Pregnane X Receptor-Mediated CYP3A4 Induction Risk. Journal of Chemical Information and Modeling 63:1, pages 173-186.
Crossref
Crossref
Toshiya Ito, Kazutomo Kinoshita, Masaki Tomizawa, Shojiro Shinohara, Hiroki Nishii, Masayuki Matsushita, Kazuo Hattori, Yasunori Kohchi, Masami Kohchi, Tadakatsu Hayase, Fumio Watanabe, Kiyoshi Hasegawa, Hiroshi Tanaka, Shino Kuramoto, Kenji Takanashi & Nobuhiro Oikawa. (2022) Discovery of CH7057288 as an Orally Bioavailable, Selective, and Potent pan-TRK Inhibitor. Journal of Medicinal Chemistry 65:18, pages 12427-12444.
Crossref
Crossref
Steffen Hirte, Oliver Burk, Ammar Tahir, Matthias Schwab, Björn Windshügel & Johannes Kirchmair. (2022) Development and Experimental Validation of Regularized Machine Learning Models Detecting New, Structurally Distinct Activators of PXR. Cells 11:8, pages 1253.
Crossref
Crossref
Mingzong Li, Zenon Konteatis, Nelamangala Nagaraja, Yue Chen, Shubao Zhou, Guangning Ma, Stefan Gross, Katya Marjon, Marc L. Hyer, Everton Mandley, Max Lein, Anil K. Padyana, Lei Jin, Shuilong Tong, Rachel Peters, Joshua Murtie, Jeremy Travins, Matthew Medeiros, Peng Liu, Victoria Frank, Evan T. Judd, Scott A. Biller, Kevin M. Marks, Zhihua Sui & Samuel K. Reznik. (2022) Leveraging Structure-Based Drug Design to Identify Next-Generation MAT2A Inhibitors, Including Brain-Penetrant and Peripherally Efficacious Leads. Journal of Medicinal Chemistry 65:6, pages 4600-4615.
Crossref
Crossref
Wei Zhu, Song Yang, Hongying Yun & Hong C. Shen. 2022. Contemporary Accounts in Drug Discovery and Development. Contemporary Accounts in Drug Discovery and Development
85
111
.
Victoria Yurchenko & Alexey Morozov. (2021) Responses of hepatic biotransformation and antioxidant enzymes in Japanese medaka (Oryzias latipes) exposed to humic acid. Fish Physiology and Biochemistry 48:1, pages 1-13.
Crossref
Crossref
Dandan Xiang & Qiangwei Wang. (2021) PXR-mediated organophorous flame retardant tricresyl phosphate effects on lipid homeostasis. Chemosphere 284, pages 131250.
Crossref
Crossref
Joshi M. Ramanjulu, Shawn P. Williams, Ami S. Lakdawala, Michael P. DeMartino, Yunfeng Lan & Robert W. Marquis. (2021) Overcoming the Pregnane X Receptor Liability: Rational Design to Eliminate PXR-Mediated CYP Induction. ACS Medicinal Chemistry Letters 12:9, pages 1396-1404.
Crossref
Crossref
Hua Lv, Wei Zhu & Hong Shen. 2021. The Medicinal Chemist's Guide to Solving ADMET Challenges. The Medicinal Chemist's Guide to Solving ADMET Challenges
198
219
.
Adrian Hall, Hugues Chanteux, Karelle MénochetMarie Ledecq & Monika-Sarah E. D. Schulze. (2021) Designing Out PXR Activity on Drug Discovery Projects: A Review of Structure-Based Methods, Empirical and Computational Approaches. Journal of Medicinal Chemistry 64:10, pages 6413-6522.
Crossref
Crossref
Zenon D. Konteatis & Zhihua Sui. 2021. Successful Drug Discovery. Successful Drug Discovery
249
271
.
Islam Husain, Vamshi Manda, Manal Alhusban, Olivia R. Dale, Ji-Yeong Bae, Bharathi Avula, Bill J. Gurley, Amar G. Chittiboyina, Ikhlas A. Khan & Shabana I. Khan. (2021) Modulation of CYP3A4 and CYP2C9 activity by Bulbine natalensis and its constituents: An assessment of HDI risk of B. natalensis containing supplements. Phytomedicine 81, pages 153416.
Crossref
Crossref
Jun-ichi Kobayashi, Hideaki Hirasawa, Yoshikazu Fujimori, Osamu Nakanishi, Noboru Kamada, Tetsuya Ikeda, Akitoshi Yamamoto & Hiroki Kanbe. (2021) Identification of N-acyl-N-indanyl-α-phenylglycinamides as selective TRPM8 antagonists designed to mitigate the risk of adverse effects. Bioorganic & Medicinal Chemistry 30, pages 115903.
Crossref
Crossref
Michael J. Bower, Alex M. Aronov, Thomas Cleveland, Niresh Hariparsad, Georgia B. McGaughey, Daniel R. McMasters, Xiaodan Zhang & Brian Goldman. (2020) Smallest Maximum Intramolecular Distance: A Novel Method to Mitigate Pregnane Xenobiotic Receptor Activation. Journal of Chemical Information and Modeling 60:4, pages 2091-2099.
Crossref
Crossref
Harutoshi Kato. (2020) Computational prediction of cytochrome P450 inhibition and induction. Drug Metabolism and Pharmacokinetics 35:1, pages 30-44.
Crossref
Crossref
Xianfeng Lin, Houguang Shi, Weixing Zhang, Zongxing Qiu, Zheng Zhou, Fabian Dey, Sheng Zhong, Hongxia Qiu, Jianxun Xie, Xue Zhou, Guang Yang, Guozhi Tang, Hong C. Shen & Wei Zhu. (2019) A New Approach of Mitigating CYP3A4 Induction Led to the Discovery of Potent Hepatitis B Virus (HBV) Capsid Inhibitor with Optimal ADMET Profiles. Journal of Medicinal Chemistry 62:22, pages 10352-10361.
Crossref
Crossref
Thilo Focken, Kristen Burford, Michael E. Grimwood, Alla Zenova, Jean-Christophe Andrez, Wei Gong, Michael Wilson, Matt Taron, Shannon Decker, Verner Lofstrand, Sultan Chowdhury, Noah Shuart, Sophia Lin, Samuel J. Goodchild, Clint Young, Maegan Soriano, Parisa K. Tari, Matthew Waldbrook, Karen Nelkenbrecher, Rainbow Kwan, Andrea Lindgren, Gina de Boer, Stephanie Lee, Luis Sojo, Robert J. DeVita, Charles J. Cohen, Steven S. Wesolowski, J. P. JohnsonJr.Jr., Christoph M. Dehnhardt & James R. Empfield. (2019)
Identification of CNS-Penetrant Aryl Sulfonamides as Isoform-Selective Na
V
1.6 Inhibitors with Efficacy in Mouse Models of Epilepsy
. Journal of Medicinal Chemistry 62:21, pages 9618-9641.
Crossref
Crossref
Janeta Popovici-Muller, René M. Lemieux, Erin Artin, Jeffrey O. Saunders, Francesco G. Salituro, Jeremy Travins, Giovanni Cianchetta, Zhenwei Cai, Ding Zhou, Dawei Cui, Ping Chen, Kimberly Straley, Erica Tobin, Fang Wang, Muriel D. David, Virginie Penard-Lacronique, Cyril Quivoron, Véronique Saada, Stéphane de Botton, Stefan Gross, Lenny Dang, Hua Yang, Luke Utley, Yue Chen, Hyeryun Kim, Shengfang Jin, Zhiwei Gu, Gui Yao, Zhiyong Luo, Xiaobing Lv, Cheng Fang, Liping Yan, Andrew Olaharski, Lee Silverman, Scott Biller, Shin-San M. Su & Katharine Yen. (2018) Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers. ACS Medicinal Chemistry Letters 9:4, pages 300-305.
Crossref
Crossref
Bhargavi Narayanan, Julie M. Lade, Carley J. S. Heck, Kevin D. Dietz, Herschel Wade & Namandjé N. Bumpus. (2018) Probing Ligand Structure–Activity Relationships in Pregnane X Receptor (PXR): Efavirenz and 8‐Hydroxyefavirenz Exhibit Divergence in Activation. ChemMedChem 13:7, pages 736-747.
Crossref
Crossref
Matthew M. Weiss, Thomas A. Dineen, Isaac E. Marx, Steven Altmann, Alessandro Boezio, Howard Bregman, Margaret Chu-Moyer, Erin F. DiMauro, Elma Feric Bojic, Robert S. Foti, Hua Gao, Russell Graceffa, Hakan Gunaydin, Angel Guzman-Perez, Hongbing Huang, Liyue Huang, Michael Jarosh, Thomas Kornecook, Charles R. Kreiman, Joseph Ligutti, Daniel S. La, Min-Hwa Jasmine Lin, Dong Liu, Bryan D. Moyer, Hanh N. Nguyen, Emily A. Peterson, Paul E. Rose, Kristin Taborn, Beth D. Youngblood, Violeta Yu & Robert T. FremeauJr.Jr.. (2017)
Sulfonamides as Selective Na
V
1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities
. Journal of Medicinal Chemistry 60:14, pages 5969-5989.
Crossref
Crossref
Nao Torimoto-Katori, Ruili Huang, Harutoshi Kato, Rikiya Ohashi & Menghang Xia. (2017) In Silico Prediction of hPXR Activators Using Structure-Based Pharmacophore Modeling. Journal of Pharmaceutical Sciences 106:7, pages 1752-1759.
Crossref
Crossref
S.A. Rosenberg, M. Xia, R. Huang, N.G. Nikolov, E.B. Wedebye & M. Dybdahl. (2017) QSAR development and profiling of 72,524 REACH substances for PXR activation and CYP3A4 induction. Computational Toxicology 1, pages 39-48.
Crossref
Crossref
Beth Williamson, Mathias Lorbeer, Michael D. Mitchell, Timothy G. Brayman & Robert J. Riley. (2016)
Evaluation of a novel PXR-knockout in HepaRG
™
cells
. Pharmacology Research & Perspectives 4:5, pages e00264.
Crossref
Crossref
Edward J. Hennessy, Vibha Oza, Ammar Adam, Kate Byth, Lillian Castriotta, Gurmit Grewal, Geraldine A. Hamilton, Victor M. Kamhi, Paula Lewis, Danyang Li, Paul Lyne, Linda Öster, Michael T. Rooney, Jamal C. Saeh, Li Sha, Qibin Su, Shengua Wen, Yafeng Xue & Bin Yang. (2015) Identification and Optimization of Benzimidazole Sulfonamides as Orally Bioavailable Sphingosine 1-Phosphate Receptor 1 Antagonists with in Vivo Activity. Journal of Medicinal Chemistry 58:17, pages 7057-7075.
Crossref
Crossref
Huali Shi, Sheng Tian, Youyong Li, Dan Li, Huidong Yu, Xuechu Zhen & Tingjun Hou. (2014) Absorption, Distribution, Metabolism, Excretion, and Toxicity Evaluation in Drug Discovery. 14. Prediction of Human Pregnane X Receptor Activators by Using Naive Bayesian Classification Technique. Chemical Research in Toxicology 28:1, pages 116-125.
Crossref
Crossref
David Barnes-Seeman, Carri Boiselle, Christina Capacci-Daniel, Rajiv Chopra, Keith Hoffmaster, Christopher T. Jones, Mitsunori Kato, Kai Lin, Sue Ma, Guoyu Pan, Lei Shu, Jianling Wang, Leah Whiteman, Mei Xu, Rui Zheng & Jiping Fu. (2014) Design and synthesis of lactam–thiophene carboxylic acids as potent hepatitis C virus polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters 24:16, pages 3979-3985.
Crossref
Crossref
James S. ScottFrederick W. GoldbergAndrew V. Turnbull. (2013) Medicinal Chemistry of Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1). Journal of Medicinal Chemistry 57:11, pages 4466-4486.
Crossref
Crossref
Nanjing Zhang, Xiaoyan Zhang, Jin Zhu, Anthony Turpoff, Guangming Chen, Christie Morrill, Song Huang, William Lennox, Ramesh Kakarla, Ronggang Liu, Chunshi Li, Hongyu Ren, Neil Almstead, Srikanth Venkatraman, F. George Njoroge, Zhengxian Gu, Valerie Clausen, Jason Graci, Stephen P. Jung, Yingcong Zheng, Joseph M. Colacino, Fred Lahser, Josephine Sheedy, Anna Mollin, Marla Weetall, Amin Nomeir & Gary M. Karp. (2013) Structure–Activity Relationship (SAR) Optimization of 6-(Indol-2-yl)pyridine-3-sulfonamides: Identification of Potent, Selective, and Orally Bioavailable Small Molecules Targeting Hepatitis C (HCV) NS4B. Journal of Medicinal Chemistry 57:5, pages 2121-2135.
Crossref
Crossref
Frederick W. Goldberg, Alexander G. Dossetter, James S. Scott, Graeme R. Robb, Scott Boyd, Sam D. Groombridge, Paul D. Kemmitt, Tove Sjögren, Pablo Morentin Gutierrez, Joanne deSchoolmeester, John G. Swales, Andrew V. Turnbull & Martin J. Wild. (2014) Optimization of Brain Penetrant 11β-Hydroxysteroid Dehydrogenase Type I Inhibitors and in Vivo Testing in Diet-Induced Obese Mice. Journal of Medicinal Chemistry 57:3, pages 970-986.
Crossref
Crossref
Anthony A. Estrada, Bryan K. Chan, Charles Baker-Glenn, Alan Beresford, Daniel J. Burdick, Mark Chambers, Huifen Chen, Sara L. Dominguez, Jennafer Dotson, Jason Drummond, Michael Flagella, Reina Fuji, Andrew Gill, Jason Halladay, Seth F. Harris, Timothy P. Heffron, Tracy Kleinheinz, Donna W. Lee, Claire E. Le Pichon, Xingrong Liu, Joseph P. Lyssikatos, Andrew D. Medhurst, John G. Moffat, Kevin Nash, Kimberly Scearce-Levie, Zejuan Sheng, Daniel G. Shore, Susan Wong, Shuo Zhang, Xiaolin Zhang, Haitao Zhu & Zachary K. Sweeney. (2014) Discovery of Highly Potent, Selective, and Brain-Penetrant Aminopyrazole Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors. Journal of Medicinal Chemistry 57:3, pages 921-936.
Crossref
Crossref
Shuya Yoshida & Fumiyoshi Yamashita. (2014) Prediction of drug-drug interaction relating to the induction of drug metabolizing enzymes. Drug Delivery System 29:5, pages 417-425.
Crossref
Crossref
Stalin Selvaraj, Ramya Ramanathan, Varshini Vasudevaraja, Kalpoondi Sekar Rajan, Sridharan Krishnaswamy, Brindha Pemiah, Swaminathan Sethuraman, Vigneshwar Ramakrishnan & Uma Maheswari Krishnan. (2014) Transcriptional regulation of the pregnane-X receptor by the Ayurvedic formulation Chandraprabha Vati. RSC Adv. 4:110, pages 64967-64976.
Crossref
Crossref
Ákos Tarcsay & György M. Keserű. 2014. Protein Modelling. Protein Modelling
287
322
.
Karl‐Heinz Baringhaus, Gerhard Hessler, Hans Matter & Friedemann Schmidt. 2013. Chemoinformatics for Drug Discovery. Chemoinformatics for Drug Discovery
245
265
.
Michael W. Sinz. 2015. Tactics in Contemporary Drug Design. Tactics in Contemporary Drug Design
159
190
.
Hans Matter, Lennart T. Anger, Clemens Giegerich, Stefan Güssregen, Gerhard Hessler & Karl-Heinz Baringhaus. (2012) Development of in silico filters to predict activation of the pregnane X receptor (PXR) by structurally diverse drug-like molecules. Bioorganic & Medicinal Chemistry 20:18, pages 5352-5365.
Crossref
Crossref
Marianne Dybdahl, Nikolai G. Nikolov, Eva Bay Wedebye, Svava ?sk J?nsd?ttir & Jay R. Niemel?. (2012) QSAR model for human pregnane X receptor (PXR) binding: Screening of environmental chemicals and correlations with genotoxicity, endocrine disruption and teratogenicity. Toxicology and Applied Pharmacology 262:3, pages 301-309.
Crossref
Crossref
Aik Jiang Lau, Guixiang Yang, Chun Wei Yap & Thomas K. H. Chang. (2012) Selective Agonism of Human Pregnane X Receptor by Individual Ginkgolides. Drug Metabolism and Disposition 40:6, pages 1113-1121.
Crossref
Crossref
Adrian J. Fretland, Anshul Gupta, Peijuan Zhu & Catherine L. Booth‐Genthe. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development
233
251
.
Johannes Kirchmair, Mark J. Williamson, Jonathan D. Tyzack, Lu Tan, Peter J. Bond, Andreas Bender & Robert C. Glen. (2012) Computational Prediction of Metabolism: Sites, Products, SAR, P450 Enzyme Dynamics, and Mechanisms. Journal of Chemical Information and Modeling 52:3, pages 617-648.
Crossref
Crossref
Shuya Yoshida, Fumiyoshi Yamashita, Takayuki Itoh & Mitsuru Hashida. (2012) Structure-Activity Relationship Modeling for Predicting Interactions with Pregnane X Receptor by Recursive Partitioning. Drug Metabolism and Pharmacokinetics 27:5, pages 506-512.
Crossref
Crossref
Sandhya Kortagere, Matthew D. Krasowski & Sean Ekins. 2012. Computational Toxicology. Computational Toxicology
359
375
.
Friederike Stoll, Andreas H. Göller & Alexander Hillisch. (2011) Utility of protein structures in overcoming ADMET-related issues of drug-like compounds. Drug Discovery Today 16:11-12, pages 530-538.
Crossref
Crossref
Wanying Sun, Milana Maletic, Steven S. Mundt, Kashmira Shah, Hratch Zokian, Kathy Lyons, Sherman T. Waddell & James Balkovec. (2011) Substituted phenyl triazoles as selective inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1. Bioorganic & Medicinal Chemistry Letters 21:7, pages 2141-2145.
Crossref
Crossref
Milana Maletic, Aaron Leeman, Michael Szymonifka, Steven S. Mundt, Hratch J. Zokian, Kashmira Shah, Jasminka Dragovic, Kathy Lyons, Rolf Thieringer, Anne H. Vosatka, James Balkovec & Sherman T. Waddell. (2011) Bicyclo[2.2.2]octyltriazole inhibitors of 11β-hydoxysteroid dehydrogenase type 1. Pharmacological agents for the treatment of metabolic syndrome. Bioorganic & Medicinal Chemistry Letters 21:8, pages 2568-2572.
Crossref
Crossref
Thomas S. Reger, Zhi-Qiang Yang, Kelly-Ann S. Schlegel, Youheng Shu, Christa Mattern, Rowena Cube, Kenneth E. Rittle, Georgia B. McGaughey, George D. Hartman, Cuyue Tang, Jeanine Ballard, Yuhsin Kuo, Thomayant Prueksaritanont, Cindy E. Nuss, Scott M. Doran, Steven V. Fox, Susan L. Garson, Yuxing Li, Richard L. Kraus, Victor N. Uebele, John J. Renger & James C. Barrow. (2011) Pyridyl amides as potent inhibitors of T-type calcium channels. Bioorganic & Medicinal Chemistry Letters 21:6, pages 1692-1696.
Crossref
Crossref
Yongmei Pan, Linhao Li, Gregory Kim, Sean Ekins, Hongbing Wang & Peter W. Swaan. (2011) Identification and Validation of Novel Human Pregnane X Receptor Activators among Prescribed Drugs via Ligand-Based Virtual Screening. Drug Metabolism and Disposition 39:2, pages 337-344.
Crossref
Crossref
Zhi-Qiang Yang, Kelly-Ann S. Schlegel, Youheng Shu, Thomas S. Reger, Rowena Cube, Christa Mattern, Paul J. Coleman, Jim Small, George D. Hartman, Jeanine Ballard, Cuyue Tang, Yuhsin Kuo, Thomayant Prueksaritanont, Cindy E. Nuss, Scott Doran, Steve V. Fox, Susan L. Garson, Yuxing Li, Richard L. Kraus, Victor N. Uebele, Adekemi B. Taylor, Wei Zeng, Wei Fang, Cynthia Chavez-Eng, Matthew D. Troyer, Julie Ann Luk, Tine Laethem, William O. Cook, John J. Renger & James C. Barrow. (2010) Short-Acting T-Type Calcium Channel Antagonists Significantly Modify Sleep Architecture in Rodents. ACS Medicinal Chemistry Letters 1:9, pages 504-509.
Crossref
Crossref
Kelly-Ann S. Schlegel, Zhi-Qiang Yang, Thomas S. Reger, Youheng Shu, Rowena Cube, Kenneth E. Rittle, Phung Bondiskey, Mark G. Bock, George D. Hartman, Cuyue Tang, Jeanine Ballard, Yuhsin Kuo, Thomayant Prueksaritanont, Cindy E. Nuss, Scott M. Doran, Steven V. Fox, Susan L. Garson, Richard L. Kraus, Yuxing Li, Victor N. Uebele, John J. Renger & James C. Barrow. (2010) Discovery and expanded SAR of 4,4-disubstituted quinazolin-2-ones as potent T-type calcium channel antagonists. Bioorganic & Medicinal Chemistry Letters 20:17, pages 5147-5152.
Crossref
Crossref
James C. Barrow, Kenneth E. Rittle, Thomas S. Reger, Zhi-Qiang Yang, Phung Bondiskey, Georgia B. McGaughey, Mark G. Bock, George D. Hartman, Cuyue Tang, Jeanine Ballard, Yuhsin Kuo, Thomayant Prueksaritanont, Cindy E. Nuss, Scott M. Doran, Steven V. Fox, Susan L. Garson, Richard L. Kraus, Yuxing Li, Michael J. Marino, Valerie Kuzmick Graufelds, Victor N. Uebele & John J. Renger. (2010) Discovery of 4,4-Disubstituted Quinazolin-2-ones as T-Type Calcium Channel Antagonists. ACS Medicinal Chemistry Letters 1:2, pages 75-79.
Crossref
Crossref
Philip J. Hamzik & Jason D. Brubaker. (2010)
Reactions of Oxetan-3-
tert
-butylsulfinimine for the Preparation of Substituted 3-Aminooxetanes
. Organic Letters 12:5, pages 1116-1119.
Crossref
Crossref
Kurt Zimmermann, Mark D. Wittman, Mark G. Saulnier, Upender Velaparthi, Xiaopeng Sang, David B. Frennesson, Charles Struzynski, Steven P. Seitz, Liqi He, Joan M. Carboni, Aixin Li, Ann F. Greer, Marco Gottardis, Ricardo M. Attar, Zheng Yang, Praveen Balimane, Lorell N. Discenza, Francis Y. Lee, Michael Sinz, Sean Kim & Dolatrai Vyas. (2010) SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 20:5, pages 1744-1748.
Crossref
Crossref
Hao Sun & Dennis O. Scott. (2010) Structure-based Drug Metabolism Predictions for Drug Design. Chemical Biology & Drug Design 75:1, pages 3-17.
Crossref
Crossref
Edward L. Lecluyse, Michael W. Sinz, Nicola Hewitt, Stephen S. Ferguson & Jasminder Sahi. 2009. Enzyme Inhibition in Drug Discovery and Development. Enzyme Inhibition in Drug Discovery and Development
265
314
.
Sean Ekins, Sandhya Kortagere, Manisha Iyer, Erica J. Reschly, Markus A. Lill, Matthew R. Redinbo & Matthew D. Krasowski. (2009) Challenges Predicting Ligand-Receptor Interactions of Promiscuous Proteins: The Nuclear Receptor PXR. PLoS Computational Biology 5:12, pages e1000594.
Crossref
Crossref
Stefanie D. Krämer & Bernard Testa. (2009) The Biochemistry of Drug Metabolism – An Introduction. Chemistry & Biodiversity 6:10, pages 1477-1660.
Crossref
Crossref
Valeria Chu, Heidi J. Einolf, Raymond Evers, Gondi Kumar, David Moore, Sharon Ripp, Jose Silva, Vikram Sinha, Michael Sinz & Andrej Skerjanec. (2009) In Vitro and in Vivo Induction of Cytochrome P450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective. Drug Metabolism and Disposition 37:7, pages 1339-1354.
Crossref
Crossref
Ni Ai, Matthew D. Krasowski, William J. Welsh & Sean Ekins. (2009) Understanding nuclear receptors using computational methods. Drug Discovery Today 14:9-10, pages 486-494.
Crossref
Crossref
Chia-Wei Li, Gia Khanh Dinh & J. Don Chen. (2009) Preferential Physical and Functional Interaction of Pregnane X Receptor with the SMRTα Isoform. Molecular Pharmacology 75:2, pages 363-373.
Crossref
Crossref
Christopher Fotsch, Michael D. Bartberger, Eric A. Bercot, Michelle Chen, Rod Cupples, Maury Emery, Jenne Fretland, Anil Guram, Clarence Hale, Nianhe Han, Dean Hickman, Randall W. Hungate, Michael Hayashi, Renee Komorowski, Qingyian Liu, Guy Matsumoto, David J. St. JeanJr.Jr., Stefania Ursu, Murielle Véniant, Guifen Xu, Qiuping Ye, Chester Yuan, Jiandong Zhang, Xiping Zhang, Hua Tu & Minghan Wang. (2008)
Further Studies with the 2-Amino-1,3-thiazol-4(5
H
)-one Class of 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors: Reducing Pregnane X Receptor Activity and Exploring Activity in a Monkey Pharmacodynamic Model
. Journal of Medicinal Chemistry 51:24, pages 7953-7967.
Crossref
Crossref
Upender Velaparthi, Mark Wittman, Peiying Liu, Joan M. Carboni, Francis Y. Lee, Ricardo Attar, Praveen Balimane, Wendy Clarke, Michael W. Sinz, Warren Hurlburt, Karishma Patel, Lorell Discenza, Sean Kim, Marco Gottardis, Ann Greer, Aixin Li, Mark Saulnier, Zheng Yang, Kurt Zimmermann, George Trainor & Dolatrai Vyas. (2008)
Discovery and Evaluation of 4-(2-(4-chloro-1
H
-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1
H
-benzo[
d
]imidazol-2-yl)pyridin-2(1
H
)-one (BMS-695735), an Orally Efficacious Inhibitor of Insulin-like Growth Factor-1 Receptor Kinase with Broad Spectrum in Vivo Antitumor Activity
. Journal of Medicinal Chemistry 51:19, pages 5897-5900.
Crossref
Crossref
Kazuto Yasuda, Aarati Ranade, Raman Venkataramanan, Stephen Strom, Jonathan Chupka, Sean Ekins, Erin Schuetz & Kenneth Bachmann. (2008) A Comprehensive in Vitro and in Silico Analysis of Antibiotics That Activate Pregnane X Receptor and Induce CYP3A4 in Liver and Intestine. Drug Metabolism and Disposition 36:8, pages 1689-1697.
Crossref
Crossref
Akash KhandelwalMatthew D. KrasowskiErica J. ReschlyMichael W. SinzPeter W. SwaanSean Ekins. (2008) Machine Learning Methods and Docking for Predicting Human Pregnane X Receptor Activation. Chemical Research in Toxicology 21:7, pages 1457-1467.
Crossref
Crossref
Michael Sinz, Gillian Wallace & Jasminder Sahi. (2008) Current Industrial Practices in Assessing CYP450 Enzyme Induction: Preclinical and Clinical. The AAPS Journal 10:2, pages 391-400.
Crossref
Crossref
Yuping Zhu, Steven H. Olson, Anne Hermanowski-Vosatka, Steven Mundt, Kashmira Shah, Marty Springer, Rolf Thieringer, Samuel Wright, Jianying Xiao, Hratch Zokian & James M. Balkovec. (2008) 4-Methyl-5-phenyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I. Bioorganic & Medicinal Chemistry Letters 18:11, pages 3405-3411.
Crossref
Crossref
Christine Healan-Greenberg, Jeffrey F. Waring, Dale J. Kempf, Eric A. G. Blomme, Rommel G. Tirona & Richard B. Kim. (2008) A Human Immunodeficiency Virus Protease Inhibitor Is a Novel Functional Inhibitor of Human Pregnane X Receptor. Drug Metabolism and Disposition 36:3, pages 500-507.
Crossref
Crossref
. 2008. Antitargets. Antitargets.
Michael W. Sinz. 2008.
405
418
.